An interim analysis of a Phase III trial showed pembrolizumab plus chemotherapy significantly improved survival in endometrial cancer. #clinicaltrials #EPRTalks
Read on: europeanpharmaceuticalreview.com/news/179236/pe
read image description
ALT
1
Follow
Click to Follow PharmaReview
European Pharmaceutical Review
@PharmaReview
The leading FREE journal for up-to-the-minute information and news on all aspects of drug analysis, formulation, delivery, manufacturing and regulation.
European Pharmaceutical Review’s Tweets
The ABPI has urged immediate government action is needed against the planned UK statutory revenue clawback rate rise for branded medicines. #pharmaceuticalindustry #EPRTalks
Read more: europeanpharmaceuticalreview.com/news/179225/ab
read image description
ALT
How do #inhalation delivery systems work and what are the advantages?
These questions (and more) will be answered by industry experts on Tuesday 28 February at 15:00 GMT! Register for your free place today: bit.ly/3Rx4IEF
#APIs #drugdelivery #DPI
A new manufacturing facility for sterile injectable drugs has opened in France, housing lines for products such as antibody drug conjugates. #pharmaceuticalmanufacturing #EPRTalks
Find out more: europeanpharmaceuticalreview.com/news/179214/fr
read image description
ALT
The MHRA has approved the first marketing authorisation globally for the use of upadacitinib in Crohn's disease.
#pharmaceuticalindustry #EPRTalks
Read more: europeanpharmaceuticalreview.com/news/179158/mh
read image description
ALT
With manufacturing of essential medicines in Europe at risk, Teva’s Phillippe Drechsle looks at the action needed to stop further offshoring to Asia...
europeanpharmaceuticalreview.com/article/179121
#Manufacuring #Generics
read image description
ALT
Curious how real-time PCR can be implemented as a sterility testing method for ATMPs?
Experts will discuss this (and more) during our free one-hour session: bit.ly/3vzJ2h1
#atmps #sterility #QAQC #cleanrooms
1
AMJEVITA™, the first biosimilar to Humira® is now available in the US, based on four years of real-world experience in over 300,000 patients.
#biosimilars #EPRTalks
Learn more: europeanpharmaceuticalreview.com/news/179151/fi
read image description
ALT
1
1
Read this whitepaper to understand the power of digital technologies in advancing medication adherence during clinical trials. europeanpharmaceuticalreview.com/whitepaper/179
2
Awards for innovative drug delivery solutions and recyclable packaging have been announced at Pharmapack Europe 2023. #packaging #EPRTalks
Find out more: europeanpharmaceuticalreview.com/news/179132/ph
read image description
ALT
Use of the Clinical Trials Information System is now mandatory for new EU clinical trial applications, says the European Medicines Agency.
#clinicaltrials #EPRTalks
Learn more: europeanpharmaceuticalreview.com/news/179088/cl
read image description
ALT
Join this webinar on capsule-based dry powder inhalers (cDPI) to discover how capsules work as a unit dosage form for the inhalation-based delivery of the active pharmaceutical ingredients. europeanpharmaceuticalreview.com/webinar/179087
Research suggests that the global sterility testing market will see a nearly $200b increase in new product spending in the next five years.
#pharmaceuticalindustry #EPRTalks
Find out more: europeanpharmaceuticalreview.com/news/179072/ph
read image description
ALT
AD | A non-hygroscopic, direct compression filler-binder such as galenIQ™ 721 is needed to produce highly stable tablets. Get high content uniformity, ease production and up patient compliance!
bit.ly/3X4oM3d
#Excipients #galenIQ #Tableets
Dupixent® has been approved by European Commission as the first and only targeted medicine indicated for eosinophilic esophagitis. #biologics #EPRTalks
See more: europeanpharmaceuticalreview.com/news/179054/fi
read image description
ALT
The Medicines Patent Pool (MPP)'s 2023-2025 strategy plans to expand access by improving the availability of innovative medicines in LMICs.
#pharmaceutical #EPRTalks
Read more: europeanpharmaceuticalreview.com/news/179045/th
read image description
ALT
Join this webinar to hear about the latest in microbiological monitoring tools that can help you implement corrective actions in real time. europeanpharmaceuticalreview.com/webinar/178879
A positive opinion has been adopted by the CHMP for a citrate-free high concentration formulation of its biosimilar Hyrimoz® (adalimumab).
#formulation #EPRTalks
Read more: europeanpharmaceuticalreview.com/news/179021/ci
read image description
ALT
1
The first BTK inhibitor of any kind approved for mantle cell lymphoma treated with a covalent BTK inhibitor, has been granted FDA approval.
#oncology #EPRTalks
Learn more: europeanpharmaceuticalreview.com/news/179016/fd
read image description
ALT
1
Four new medicines were recommended for approval at the CHMP’s January meeting, with positive opinions given to two type 2 diabetes drugs.
#DrugSafety #EPRTalks
Read more: europeanpharmaceuticalreview.com/news/179004/ch
read image description
ALT
1
1
Based on a trial results, a "potential game changer” approach could offer a practical way to use monoclonal antibodies for malaria in Africa.
#clinicaltrials #EPRTalks
Read more: europeanpharmaceuticalreview.com/news/178968/mo
read image description
ALT
$1.15m from Eli Lilly will support a new cold chain capacity initiative in low- and middle-income countries, to help improve medicine access. #supplychain #EPRTalks
Find out more: europeanpharmaceuticalreview.com/news/178962/el
read image description
ALT
A first-of-its-kind regulatory framework for point of care manufacturing of innovative medicines is set to be introduced in the UK. #pharmaceuticalmanufacturing #EPRTalks
Read on: europeanpharmaceuticalreview.com/news/178955/ne
read image description
ALT
The has approved Enhertu as the first HER2-directed therapy for patients with HER2-low metastatic breast cancer. #BreastCancer #EPRTalks
Read on: europeanpharmaceuticalreview.com/news/178941/en
read image description
ALT
Download Thermo Fisher Scientific's new ebook for an in-depth look at advanced analytical methods for extractables and leachables analysis:
europeanpharmaceuticalreview.com/article/178202
#AnalyticalTechniques #QualityControl
read image description
ALT
An updated Q&A document for ICH M10 'Bioanalytical Method Validation and Study Sample Analysis’ has been published by the EMA. #pharmaceuticalindustry #EPRTalks
Read more: europeanpharmaceuticalreview.com/news/178910/em
read image description
ALT
Key stakeholders in the medicine supply chain have been urged by WHO to take immediate action against recent cases of contaminated medicines. #supplychain #EPRTalks
Learn more: europeanpharmaceuticalreview.com/news/178891/wh
read image description
ALT
One of the largest studies for a short-acting psychedelic showed a remission rate of 57 percent for depression after a single dose of DMT. #clinicaltrials #EPRTalks
Read now: europeanpharmaceuticalreview.com/news/178880/ma
read image description
ALT
1
A marketing application, the first regulatory submission for a CRISPR-based therapy, has been validated by the .
#CellTherapy #EPRTalks
Read now: europeanpharmaceuticalreview.com/news/178870/em
read image description
ALT
1
1
AD | Dissolve the hurdles around fizzy tablet production with a sweet filler binder. It makes manufacturing easier and patient’s acceptance better! #Tablets #Excipients
bit.ly/3X4oM3d
1
1
Three all-female key leaders in Europe have been hired by Velocity Clinical Research, the largest clinical sites business globally.
#pharmaceuticalindustry #EPRTalks
View now: europeanpharmaceuticalreview.com/news/178848/la
read image description
ALT
Takeda and HUTCHMED have entered into an exclusive licensing agreement, to develop oral fruquintinib for colorectal cancer outside China.
#drugdevelopment #EPRTalks
Learn more: europeanpharmaceuticalreview.com/news/178838/ta
read image description
ALT
Want to advance your endotoxin and sterility testing in cell and #genetherapy?
Explore a range of rapid microbial methods and technologies enhancing rapid detection of bacterial #endotoxins by watching our on-demand sessions from #CGTMicroOnline: bit.ly/3ApEXy2
1
1
Onivyde® treatment regimen significantly improved survival in a Phase III trial compared to nab-paclitaxel plus gemcitabine.
#clinicaltrials #EPRTalks
Read on: europeanpharmaceuticalreview.com/news/178817/on
read image description
ALT
The EMA’s Medicines Shortages Steering Group have stated it is closely monitoring and responding to the current EU antibiotic shortages. #pharmaceuticalmanufacturing #EPRTalks
read image description
ALT
2
2
A complete response letter for Eli Lilly's accelerated approval submission of donanemab for early Alzheimer's has been issued by the .
#alzheimersdisease #EPRTalks
Find out more: europeanpharmaceuticalreview.com/news/178756/fd
read image description
ALT
BRUKINSA® (zanubrutinib) has been authorised by the for chronic lymphocytic leukaemia and marginal zone lymphoma in Great Britain. #drugdevelopment #EPRTalks
Read the full story: europeanpharmaceuticalreview.com/news/178748/mh
read image description
ALT
IMbrave050 is the first Phase III study to show a cancer immunotherapy combo reduced risk of disease recurrence for hepatocellular carcinoma.
#clinicaltrials #EPRTalks
Learn more: europeanpharmaceuticalreview.com/news/178720/cl
read image description
ALT
The Robert A. Winn Diversity in Clinical Trials Award Program has been pledged $8 million over the next four years by . #clinicaltrials #EPRTalks
read image description
ALT